Group 1 - Huangdi Tea Shop officially announces plans for an initial public offering (IPO) in the United States, marking a significant step towards global brand expansion and entry into the U.S. market [1] - The IPO aims to provide solid capital support for Huangdi Tea Shop's global growth strategy, focusing on expanding into North America, Europe, and the Asia-Pacific region, enhancing production and operational capabilities, and launching innovative tea products that blend traditional Chinese tea-making techniques with modern consumer trends [3] - Boustead APEX Inc. will serve as the strategic advisor, while Boustead and Company will act as the lead underwriter, with Raffles Capital US participating as a cornerstone investor [1][3] Group 2 - The CEO of Boustead APEX Inc. emphasizes the mission to provide strategic and compliance guidance for Huangdi Tea Shop's successful listing and global expansion [5] - Huangdi Tea Shop's CEO describes the IPO as a significant milestone in the company's development, aiming to establish the brand as a global high-end tea label [5] - Raffles Capital's founder expresses honor in being a cornerstone investor, highlighting Huangdi Tea Shop's strong brand heritage and commitment to quality as unique advantages for attracting global investors [5] Group 3 - Huangdi Tea Shop is a tea beverage company based in China, producing and selling various health teas derived from high-quality medicinal ingredients, combining traditional craftsmanship with modern operational concepts [6] - Boustead APEX Inc. provides advisory services for Asian companies entering the U.S. capital markets, including IPO planning and corporate financing [6] - Boustead and Company is a U.S.-registered securities broker offering investment banking services, including public offerings and private financing [6] - Raffles Capital invests in emerging companies with global market potential, supporting sustainable growth and value enhancement [6]